Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × UNKNOWN × Tumor-Agnostic × Clear all

Phase

Status

Sponsor Class

INDUSTRY 122 OTHER 75 NIH 6 UNKNOWN 1 OTHER_GOV 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 6 Tumor-Agnostic 1 Lymphoid 1 Head & Neck 1

Conditions

Carcinoma, Squamous Cell 1 Adenocarcinoma 1

Interventions

Pemetrexed 1 Paclitaxel 1 Clinical Trials, Phase II as Topic 1 Clinical Trials, Phase I as Topic 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03636685 2018-08-17

Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC

ChineseAMS

Phase 1/2 Unknown

Adenocarcinoma, Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡